Can inhibition of the tyrosine phosphatase SHP2 improve response to PD-1/PDL1-directed immunotherapy in lung cancers?
Guest Speaker: Penni Black, University of Kentucky
Dr. Penni Black is an Associate Professor of Pharmaceutical Sciences and Director of the Professional Program. She received her undergraduate degree from Clemson University and PhD from the University of Florida. https://pharmacy.uky.edu/people/penni-black

Hosted by Charlie Wei